These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 17711579)
1. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931 [TBL] [Abstract][Full Text] [Related]
3. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines. Wilson C; Yang J; Strefford JC; Summersgill B; Young BD; Shipley J; Oliver T; Lu YJ Genes Chromosomes Cancer; 2005 Jun; 43(2):211-6. PubMed ID: 15761863 [TBL] [Abstract][Full Text] [Related]
5. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410 [TBL] [Abstract][Full Text] [Related]
6. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. Daoud SS; Munson PJ; Reinhold W; Young L; Prabhu VV; Yu Q; LaRose J; Kohn KW; Weinstein JN; Pommier Y Cancer Res; 2003 Jun; 63(11):2782-93. PubMed ID: 12782583 [TBL] [Abstract][Full Text] [Related]
7. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness. Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922 [TBL] [Abstract][Full Text] [Related]
8. New insights into testicular germ cell tumorigenesis from gene expression profiling. Skotheim RI; Monni O; Mousses S; Fosså SD; Kallioniemi OP; Lothe RA; Kallioniemi A Cancer Res; 2002 Apr; 62(8):2359-64. PubMed ID: 11956097 [TBL] [Abstract][Full Text] [Related]
9. DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma. Minami K; Chano T; Kawakami T; Ushida H; Kushima R; Okabe H; Okada Y; Okamoto K Clin Cancer Res; 2010 May; 16(10):2751-9. PubMed ID: 20460473 [TBL] [Abstract][Full Text] [Related]
10. cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance. Samimi G; Manorek G; Castel R; Breaux JK; Cheng TC; Berry CC; Los G; Howell SB Cancer Chemother Pharmacol; 2005 Jan; 55(1):1-11. PubMed ID: 15378272 [TBL] [Abstract][Full Text] [Related]
11. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells. Fung MK; Cheung HW; Ling MT; Cheung AL; Wong YC; Wang X Br J Cancer; 2006 Aug; 95(4):475-84. PubMed ID: 16880791 [TBL] [Abstract][Full Text] [Related]
12. PCPH expression is an early event in the development of testicular germ cell tumors. Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363 [TBL] [Abstract][Full Text] [Related]
13. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer. Scurr LL; Guminski AD; Chiew YE; Balleine RL; Sharma R; Lei Y; Pryor K; Wain GV; Brand A; Byth K; Kennedy C; Rizos H; Harnett PR; deFazio A Clin Cancer Res; 2008 Nov; 14(21):6924-32. PubMed ID: 18980987 [TBL] [Abstract][Full Text] [Related]
14. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum. Ma Y; Yuan RQ; Fan S; Hu C; Goldberg ID; Laterra JJ; Rosen EM Anticancer Drugs; 2006 Aug; 17(7):733-51. PubMed ID: 16926624 [TBL] [Abstract][Full Text] [Related]
15. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours. Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927 [TBL] [Abstract][Full Text] [Related]
16. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli. Spierings DC; de Vries EG; Vellenga E; de Jong S J Pathol; 2003 Jun; 200(2):137-48. PubMed ID: 12754734 [TBL] [Abstract][Full Text] [Related]
17. A portrait of cisplatin-induced transcriptional changes in mouse embryonic stem cells reveals a dominant p53-like response. Kruse JJ; Svensson JP; Huigsloot M; Giphart-Gassler M; Schoonen WG; Polman JE; Jean Horbach G; van de Water B; Vrieling H Mutat Res; 2007 Apr; 617(1-2):58-70. PubMed ID: 17327130 [TBL] [Abstract][Full Text] [Related]
18. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin. Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316 [TBL] [Abstract][Full Text] [Related]
19. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid). Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441 [TBL] [Abstract][Full Text] [Related]
20. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]